Table 3.
Clinical and demographic characteristics of participants, categorized by PAD and non-PAD subjects. For continuous variables, mean ± standard deviation is shown. For categorical variables, the number of subjects and their percentage of the total number of subjects in the group are presented
| Factor | Non-PAD (n = 118) |
PAD (n = 118) |
p-value (Mann–Whitney U test) |
|---|---|---|---|
| HTN (n,%) | 65 (55%) | 84 (71%) | – |
| DBT duration (yarr) | 10.8 ± 9.5 | 13.5 ± 8.4 | 0.002 |
| HTN duration (year) | 5.4 ± 6.9 | 8.0 ± 8.5 | 0.009 |
| Comorbiditiesa (n, %) | 43, 36% | 48, 41% | – |
| Hyperlipidemia (n, %) | 71, 60% | 84, 71% | – |
| UIcers (n, %) | 0, 0% | 23, 19% | |
| Claudication duration (year) | – | 4.3 ± 3.9 | |
| Male (n, %) | 52, 44% | 50, 42% | – |
| Female (n, %) | 66, 56% | 68, 58% | – |
| Age (yr) | 54.8 ± 13.7 | 59.1 ± 7.9 | 0.016 |
| BMI (kg/m2) | 30.3 ± 5.9 | 31.7 ± 5.5 | 0.071 |
| Left ankle-brachial index | 1.09 ± 0.08 | 0.88 ± 0.14 | < 0.001 |
| Right ankle-brachial index | 1.10 ± 0.07 | 0.92 ± 0.11 | < 0.001 |
| Systolic blood pressure (mmHg) | 136.51 ± 17.25 | 139.86 ± 11.89 | 0.478 |
| Diastolic blood pressure (mmHg) | 74.81 ± 9.88 | 72.43 ± 8.77 | 0.402 |
| Tobacco use (n, %) | 35, 30% | 22, 19% | – |
| Anticoagulants (n, %) | 12, 10% | 14, 12% | |
| Antiaggregants (n, %) | 80, 68% | 105, 89% | |
| Statins (n, %) | 70, 59% | 75, 64% | |
| Antihypertensive (n, %) | 65, 55% | 84, 71% |
DBT diabetic, HTN hypertension, BMI body mass index
aComorbidities include myocardial infarction, coronary artery disease, cerebrovascular diseases, lung disease, lower limb revascularization.